111
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

SEPARATION AND CHARACTERIZATION OF THE IMPURITIES AND ISOMERS IN CEFMENOXIME HYDROCHLORIDE BY HPLC-UV-MSn

, &
Pages 2125-2141 | Published online: 09 Jun 2013
 

Abstract

The twelve impurities and isomers in cefmenoxime hydrochloride were separated and identified by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MSn). A discipline of mass fragmentation pattern and structure for the E-isomer and Δ3-isomer of oxime cephalosporin antibiotics was presented to distinguish their structures. The column was Alltima C18(250 × 4.6 mm, 5 µm). The mobile phase was water-acetic acid-acetonitrile (85:1:15). In positive mode, full scan LC-MS was first performed in order to obtain the m/z value of the protonated molecules of all detected peaks. LC-MS-MS and LC-MS-MS-MS were then carried out on the compounds of interest. The complete fragmentation patterns of twelve impurities were studied and used to obtain information about the structure of these impurities. The relationship of mass fragmentation pattern and structure for cefmenoxime, E-isomer of cefmenoxime and Δ3-isomer of cefmenoxime was studied. The structures of the twelve impurities and isomers in cefmenoxime hydrochloride were deduced based on the HPLC-MSn data, assisted by the UV spectra and stress testing.

Notes

Note: –, meant that the impurity content had no change.

+, meant that the impurity content increased.

+ +, meant that the impurity content increased obviously.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.